WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2022)
Top biotech stocks in 2022 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Exchange
Industry
Zen Score
Market Cap
Price
1d %
EBITDA
P/E
D/E
INCY
INCYTE CORP
NASDAQ
Biotechnology
$15.49B$69.640.20%$694.45M16.31x0.30
EXEL
EXELIXIS INC
NASDAQ
Biotechnology
$5.02B$15.60-2.38%$370.21M18.35x0.21
GMAB
GENMAB A
NASDAQ
Biotechnology
$24.14B$36.722.74%$815.98M44.40x0.12
UTHR
UNITED THERAPEUTICS CORP
NASDAQ
Biotechnology
$9.55B$209.80-1.06%$874.60M15.02x0.28
MRNA
MODERNA INC
NASDAQ
Biotechnology
$48.96B$125.15-0.37%$15.97B3.58x0.45
HALO
HALOZYME THERAPEUTICS INC
NASDAQ
Biotechnology
$5.76B$41.820.38%$256.86M16.08x5.08
VIR
VIR BIOTECHNOLOGY INC
NASDAQ
Biotechnology
$2.83B$21.34-4.09%$1.36B2.59x0.34
CSBR
CHAMPIONS ONCOLOGY INC
NASDAQ
Biotechnology
$102.23M$7.560.67%$2.28M252.00x2.83
CPRX
CATALYST PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.28B$12.47-2.12%$73.03M23.53x0.11
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
NASDAQ
Biotechnology
$2.85B$48.12-0.72%$104.97M49.10x1.05
SESN
SESEN BIO INC
NASDAQ
Biotechnology
$99.73M$0.504.17%$35.40M2.00x0.24
CORT
CORCEPT THERAPEUTICS INC
NASDAQ
Biotechnology
$2.87B$26.841.74%$134.12M26.31x0.12
VRTX
VERTEX PHARMACEUTICALS INC
NASDAQ
Biotechnology
$76.59B$298.63-1.12%$4.13B23.95x0.31
XOMA
XOMA CORP
NASDAQ
Biotechnology
$196.38M$17.153.69%$18.72M19.94x0.14
TECH
BIO-TECHNE CORP
NASDAQ
Biotechnology
$12.12B$309.080.17%$422.72M44.60x0.35
BNTX
BIONTECH SE
NASDAQ
Biotechnology
$33.42B$137.530.25%$17.28B1.74x0.26
REGN
REGENERON PHARMACEUTICALS INC
NASDAQ
Biotechnology
$79.78B$731.86-1.85%$6.70B13.71x0.32
CDMO
AVID BIOSERVICES INC
NASDAQ
Biotechnology
$1.16B$18.651.58%$16.18M9.28x1.52
SIGA
SIGA TECHNOLOGIES INC
NASDAQ
Biotechnology
$687.16M$9.41-0.32%$92.53M9.80x0.14
HUMA
HUMACYTE INC
NASDAQ
Biotechnology
$333.74M$3.241.25%$41.79M1.31x0.73
BLCM
BELLICUM PHARMACEUTICALS INC
NASDAQ
Biotechnology
$10.76M$1.254.17%-$7.76M17.86x0.32
AUPH
AURINIA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.08B$7.641.19%-$152.92M-6.59x0.14
ETON
ETON PHARMACEUTICALS INC
NASDAQ
Biotechnology
$56.92M$2.250.45%-$9.39M-4.79x0.74
APVO
APTEVO THERAPEUTICS INC
NASDAQ
Biotechnology
$15.98M$3.141.95%$8.12M2.36x0.68
BGNE
BEIGENE LTD
NASDAQ
Biotechnology
$14.58B$140.34-2.72%-$1.96B-88.82x0.39
SELB
SELECTA BIOSCIENCES INC
NASDAQ
Biotechnology
$267.25M$1.751.16%$53.13M7.00x1.10
SLGL
SOL-GEL TECHNOLOGIES LTD
NASDAQ
Biotechnology
$116.11M$5.026.36%$10.32M11.95x0.09
EFTR
EFFECTOR THERAPEUTICS INC
NASDAQ
Biotechnology
$26.32M$0.642.42%$26.06M0.32x1.22
LPCN
LIPOCINE INC
NASDAQ
Biotechnology
$42.31M$0.48-4.59%$3.53M11.95x0.06
LQDA
LIQUIDIA CORP
NASDAQ
Biotechnology
$356.57M$5.54-0.72%-$38.16M-6.76x0.36
DVAX
DYNAVAX TECHNOLOGIES CORP
NASDAQ
Biotechnology
$1.41B$11.18-1.93%$248.32M6.01x1.42
GNFT
GENFIT SA
NASDAQ
Biotechnology
$189.30M$3.80-2.56%$78.77M-0.20x1.37
CARA
CARA THERAPEUTICS INC
NASDAQ
Biotechnology
$520.60M$9.69-0.62%-$64.74M-7.69x0.11
OCUP
OCUPHIRE PHARMA INC
NASDAQ
Biotechnology
$48.57M$2.363.51%-$22.05M-2.29x0.23
ABCM
ABCAM PLC
NASDAQ
Biotechnology
$3.67B$16.03-1.23%$39.77M93.20x0.46
HCM
HUTCHMED (CHINA) LTD
NASDAQ
Biotechnology
$1.49B$8.63-7.20%-$248.68M-5.75x0.43
ATNF
180 LIFE SCIENCES CORP
NASDAQ
Biotechnology
$24.62M$0.65-2.68%$23.98M0.87x0.25
CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC
NASDAQ
Biotechnology
$7.27M$0.5212.39%-$4.86M-0.14x0.02
CLNN
CLENE INC
NASDAQ
Biotechnology
$114.30M$1.80-0.55%$18.27M6.92x-80.12
AGEN
AGENUS INC
NASDAQ
Biotechnology
$792.86M$2.8018.14%$87.05M28.00x129.55
HSTO
HISTOGEN INC
NASDAQ
Biotechnology
$3.55M$1.42-4.70%-$10.92M-0.29x0.35
OPNT
OPIANT PHARMACEUTICALS INC
NASDAQ
Biotechnology
$56.55M$10.95-1.08%-$17.29M-2.87x0.65
FUSN
FUSION PHARMACEUTICALS INC
NASDAQ
Biotechnology
$134.94M$3.110.65%-$74.35M-1.78x0.15
SPRC
SCISPARC LTD
NASDAQ
Biotechnology
$2.97M$0.966.67%-$1.74M1.12x0.22
MRUS
MERUS NV
NASDAQ
Biotechnology
$962.07M$20.973.40%-$52.56M-16.26x0.36
CLGN
COLLPLANT BIOTECHNOLOGIES LTD
NASDAQ
Biotechnology
$72.58M$6.55-3.29%-$14.27M-4.58x0.12
RPTX
REPARE THERAPEUTICS INC
NASDAQ
Biotechnology
$557.77M$13.30-1.48%-$129.10M-4.05x0.37
LOGC
LOGICBIO THERAPEUTICS INC
NASDAQ
Biotechnology
$66.91M$2.030.25%-$28.26M-2.16x1.27
LPTX
LEAP THERAPEUTICS INC
NASDAQ
Biotechnology
$88.13M$0.89-0.78%-$49.28M-1.93x0.13
ZLAB
ZAI LAB LTD
NASDAQ
Biotechnology
$3.47B$35.47-4.32%-$514.01M-6.39x0.17
BYSI
BEYONDSPRING INC
NASDAQ
Biotechnology
$40.87M$1.059.38%-$60.46M-0.64x2.07
RPRX
ROYALTY PHARMA PLC
NASDAQ
Biotechnology
$24.93B$41.06-1.61%$651.43M38.74x0.70
XENE
XENON PHARMACEUTICALS INC
NASDAQ
Biotechnology
$2.38B$38.303.15%-$90.76M-22.01x0.03
PTGX
PROTAGONIST THERAPEUTICS INC
NASDAQ
Biotechnology
$424.58M$8.650.35%-$129.48M-3.16x0.16
QURE
UNIQURE NV
NASDAQ
Biotechnology
$944.39M$20.210.50%-$98.29M-8.22x0.44
MIRM
MIRUM PHARMACEUTICALS INC
NASDAQ
Biotechnology
$650.78M$19.87-3.87%-$40.78M-12.04x1.69
LEXX
LEXARIA BIOSCIENCE CORP
NASDAQ
Biotechnology
$14.88M$2.503.31%-$7.01M-2.00x0.03
NBIX
NEUROCRINE BIOSCIENCES INC
NASDAQ
Biotechnology
$10.65B$111.382.51%$45.80M856.77x0.41
LMNL
LIMINAL BIOSCIENCES INC
NASDAQ
Biotechnology
$14.28M$0.466.98%$42.58M0.36x1.95
DBVT
DBV TECHNOLOGIES SA
NASDAQ
Biotechnology
$315.92M$1.68-2.89%-$76.34M-2.51x0.17
BNOX
BIONOMICS LIMITED
NASDAQ
Biotechnology
$60.90M$7.50-2.28%-$14.04M-2.96x0.15
EDIT
EDITAS MEDICINE INC
NASDAQ
Biotechnology
$876.40M$12.751.76%-$181.71M-4.72x0.25
SNDX
SYNDAX PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.48B$26.246.11%$3.27M124.95x0.12
GANX
GAIN THERAPEUTICS INC
NASDAQ
Biotechnology
$37.08M$3.120.00%-$16.19M-2.29x0.18
STTK
SHATTUCK LABS INC
NASDAQ
Biotechnology
$127.15M$3.001.01%-$59.36M-2.07x0.13
CLSD
CLEARSIDE BIOMEDICAL INC
NASDAQ
Biotechnology
$81.26M$1.35-1.46%-$1.46M-135.00x0.22
BMRN
BIOMARIN PHARMACEUTICAL INC
NASDAQ
Biotechnology
$16.97B$91.482.18%$177.12M315.45x0.36
JANX
JANUX THERAPEUTICS INC
NASDAQ
Biotechnology
$561.62M$13.48-4.80%-$54.20M-10.53x0.12
CGEM
CULLINAN ONCOLOGY INC
NASDAQ
Biotechnology
$592.96M$13.004.84%$157.82M5.26x0.10
ITOS
ITEOS THERAPEUTICS INC
NASDAQ
Biotechnology
$675.22M$18.98-1.40%$425.14M2.03x0.28
RGNX
REGENXBIO INC
NASDAQ
Biotechnology
$999.48M$23.121.49%$140.95M10.51x0.51
DARE
DARE BIOSCIENCE INC
NASDAQ
Biotechnology
$84.82M$1.001.01%-$30.21M-2.17x0.56
MRVI
MARAVAI LIFESCIENCES HOLDINGS INC
NASDAQ
Biotechnology
$5.34B$20.93-1.83%$380.04M10.79x3.06
EIGR
EIGER BIOPHARMACEUTICALS INC
NASDAQ
Biotechnology
$287.54M$6.54-6.84%-$84.04M-2.68x0.59
SEER
SEER INC
NASDAQ
Biotechnology
$497.76M$7.95-0.25%-$79.26M-5.80x0.09
ALEC
ALECTOR INC
NASDAQ
Biotechnology
$753.81M$9.13-1.19%$46.62M20.29x2.08
MTEM
MOLECULAR TEMPLATES INC
NASDAQ
Biotechnology
$41.70M$0.74-7.50%-$75.18M0.48x4.41
IMGN
IMMUNOGEN INC
NASDAQ
Biotechnology
$1.23B$5.59-1.24%-$158.82M-8.10x0.69
INMB
INMUNE BIO INC
NASDAQ
Biotechnology
$118.44M$6.60-0.60%-$32.87M-3.53x0.26
NHWK
NIGHTHAWK BIOSCIENCES INC
NYSEMKT
Biotechnology
$46.19M$1.80-0.55%-$38.18M-1.15x0.38
PPBT
PURPLE BIOTECH LTD
NASDAQ
Biotechnology
$39.54M$2.223.74%$19.45MN/A0.11
ASMB
ASSEMBLY BIOSCIENCES INC
NASDAQ
Biotechnology
$82.34M$1.700.59%-$128.66M-0.61x0.16
AVEO
AVEO PHARMACEUTICALS INC
NASDAQ
Biotechnology
$303.57M$8.77-3.73%-$31.41M-8.51x2.21
VACC
VACCITECH PLC
NASDAQ
Biotechnology
$123.19M$3.310.91%-$744.00k-165.50x0.12
DYAI
DYADIC INTERNATIONAL INC
NASDAQ
Biotechnology
$49.74M$1.750.57%-$11.71M-4.17x0.27
NOVN
NOVAN INC
NASDAQ
Biotechnology
$34.69M$1.630.00%-$35.02M-0.84x8.34
MREO
MEREO BIOPHARMA GROUP PLC
NASDAQ
Biotechnology
$137.89M$0.94-2.28%$24.88M8.98x0.44
KMPH
KEMPHARM INC
NASDAQ
Biotechnology
$210.41M$6.100.99%-$30.38M-2.26x0.25
CGEN
COMPUGEN LTD
NASDAQ
Biotechnology
$59.77M$0.690.00%-$33.20M-1.73x0.22
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC
NASDAQ
Biotechnology
$426.55M$16.05-0.43%-$162.15M-2.56x0.97
VCYT
VERACYTE INC
NASDAQ
Biotechnology
$1.32B$18.49-0.75%-$22.93M-27.60x0.08
CRSP
CRISPR THERAPEUTICS AG
NASDAQ
Biotechnology
$5.09B$65.260.97%-$601.68M-7.89x0.18
VCNX
VACCINEX INC
NASDAQ
Biotechnology
$26.67M$0.632.12%-$19.51M-1.10x0.15
AVIR
ATEA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$472.08M$5.67-1.05%$25.91M31.50x0.05
AADI
AADI BIOSCIENCE INC
NASDAQ
Biotechnology
$300.54M$14.30-0.14%-$134.36M-3.82x0.18
SAGE
SAGE THERAPEUTICS INC
NASDAQ
Biotechnology
$2.53B$42.663.12%-$501.94M-5.01x0.07
SGEN
SEAGEN INC
NASDAQ
Biotechnology
$25.13B$136.28-0.43%-$658.00M-33.82x0.24
TFFP
TFF PHARMACEUTICALS INC
NASDAQ
Biotechnology
$93.90M$3.69-8.44%-$35.58M-2.62x0.17
ARGX
ARGENX SE
NASDAQ
Biotechnology
$20.31B$368.77-2.15%-$923.94M-20.98x0.09
AGIO
AGIOS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.58B$28.83-0.55%-$352.89M-5.13x0.11

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Oct 2022?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the top biotech stock with a Zen Score of 74, which is 45 points higher than the biotech industry average of 29. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock return 5.8% over the past year, overperforming other biotech stocks by 45 percentage points.

Incyte has an average 1 year price target of $84.13, an upside of 20.8% from Incyte's current stock price of $69.64.

Incyte stock has a consensus Hold recommendation according to Wall Street analysts. Of the 9 analysts covering Incyte, 0% have issued a Strong Buy rating, 33.33% have issued a Buy, 55.56% have issued a hold, while 11.11% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Genmab A (NASDAQ:GMAB)


Genmab A (NASDAQ:GMAB) is the second best biotech stock with a Zen Score of 72, which is 43 points higher than the biotech industry average of 29. It passed 24 out of 33 due diligence checks and has strong fundamentals. Genmab A has seen its stock lose -14.55% over the past year, overperforming other biotech stocks by 24 percentage points.

Genmab A has an average 1 year price target of $37.15, an upside of 1.16% from Genmab A's current stock price of $36.72.

Genmab A stock has a consensus Sell recommendation according to Wall Street analysts. Of the 7 analysts covering Genmab A, 0% have issued a Strong Buy rating, 14.29% have issued a Buy, 57.14% have issued a hold, while 0% have issued a Sell rating, and 28.57% have issued a Strong Sell.

3. Exelixis (NASDAQ:EXEL)


Exelixis (NASDAQ:EXEL) is the third best biotech stock with a Zen Score of 72, which is 43 points higher than the biotech industry average of 29. It passed 23 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock lose -25.36% over the past year, overperforming other biotech stocks by 14 percentage points.

Exelixis has an average 1 year price target of $30.43, an upside of 95.06% from Exelixis's current stock price of $15.60.

Exelixis stock has a consensus Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Exelixis, 28.57% have issued a Strong Buy rating, 57.14% have issued a Buy, 14.29% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 4.78%, which is 3 percentage points higher than the biotech industry average of 1.68%.

Siga Technologies's dividend payout ratio of 46.9% indicates that its dividend yield is sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.8%, which is the same as the biotech industry average of 1.68%.

Royalty Pharma's dividend payout ratio of 67.9% indicates that its dividend yield is sustainable for the long-term.

3. Biontech Se (NASDAQ:BNTX)


Biontech Se (NASDAQ:BNTX) has an annual dividend yield of 1.53%, which is the same as the biotech industry average of 1.68%.

Biontech Se's dividend payout ratio of 2.7% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.06% in the last day, and up 4.17% over the last week. Kiromic Biopharma was the among the top gainers in the biotechnology industry, gaining 44.12% yesterday.

Kiromic BioPharma shares are trading higher after the company announced it received feedback from the FDA pursuant to its Type B Pre-IND meeting request regarding its Deltacel development strategy.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Vir Biotechnology (NASDAQ:VIR)


Vir Biotechnology (NASDAQ:VIR) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Vir Biotechnology has a valuation score of 100, which is 66 points higher than the biotech industry average of 34. It passed 7 out of 7 valuation due diligence checks.

Vir Biotechnology's stock has dropped -36.36% in the past year. It has overperformed other stocks in the biotech industry by 3 percentage points.

2. Molecular Templates (NASDAQ:MTEM)


Molecular Templates (NASDAQ:MTEM) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Molecular Templates has a valuation score of 100, which is 66 points higher than the biotech industry average of 34. It passed 7 out of 7 valuation due diligence checks.

Molecular Templates's stock has dropped -88.54% in the past year. It has underperformed other stocks in the biotech industry by -50 percentage points.

3. Moderna (NASDAQ:MRNA)


Moderna (NASDAQ:MRNA) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Moderna has a valuation score of 86, which is 52 points higher than the biotech industry average of 34. It passed 6 out of 7 valuation due diligence checks.

Moderna's stock has dropped -58.62% in the past year. It has underperformed other stocks in the biotech industry by -20 percentage points.

Are biotech stocks a good buy now?

47.87% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 95.91% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 16.62x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.